Xenon

Ver el organigrama con sus 20 ejecutivos principales

Biografías más buscadas en Xenon

• Ian Mortimer, President, Chief Executive Officer and Director
• Mohammad Azab, Director
• Steven Gannon, Director

Recientes movimientos de ejecutivos en Xenon

• Justin Gover, se ha incorporado a la empresa como Director  (noticia publicada el 9 de agosto de 2023).
• Gillian Cannon, se ha incorporado a la empresa como Director  (noticia publicada el 9 de agosto de 2023).

Crear su alerta
para seguir los movimientos de los ejecutivos en Xenon.

Xenon tiene 1.867 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).

Popular M&A news in Farmacia

• AstraZeneca has announced the acquisition of Fusion Pharma  (publicado el 23 de marzo de 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (publicado el 19 de marzo de 2024).
• Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).

Otros contactos sugeridos en el sector Farmacia

• Jean-Frédéric Paulsen - Executive Chairman of the Board en Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director en Dirk Rossmann
• Thierry Abribat - Chief Executive Officer en Amolyt Pharma

Saber más sobre el sector Farmacia >

Últimos comunicados de prensa de Xenon

• Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference | Xenon Pharmaceuticals Inc.
• Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update | Xenon Pharmaceuticals Inc.
• View more press releases Close

Redes sociales sobre Xenon

• Xenon en Wikipedia, Google News y Yahoo Finance
• Xenon en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos Ian Mortimer

Llame a Xenon al +1 604...

Ver el organigrama

Register to receive your alert

Señalar un error